ClearPoint Neuro, Inc. (CLPT) Total liabilities 2017–2025
ClearPoint Neuro, Inc. (CLPT) total liabilities at each fiscal year-end, per SEC filings.
$69.7MFY2025 · since FY2017: $8.1M → $69.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $69.7M | +405.3% |
| FY2024 | $13.8M | -35.8% |
| FY2023 | $21.5M | +15.5% |
| FY2022 | $18.6M | +10.8% |
| FY2021 | $16.8M | -38.1% |
| FY2020 | $27.1M | +269.7% |
| FY2019 | $7.3M | +15.7% |
| FY2018 | $6.3M | -21.4% |
| FY2017 | $8.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More CLPT financial trends
CLPT RevenueCLPT Net incomeCLPT Net marginCLPT Gross profitCLPT Gross marginCLPT Operating incomeCLPT Operating marginCLPT Operating cash flowCLPT Free cash flowCLPT Capital expendituresCLPT Return on equityCLPT Stock buybacksCLPT Dividends paidCLPT Total assetsCLPT Shareholders’ equityCLPT overview →